CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in EYPT — EyePoint, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,251,185
-$3,598,097 QoQ
Shares Held
640,123
-1.3% QoQ
Ownership
0.763%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. EYPT ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in EYPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,251,185 | 640,123 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,849,282 | 648,565 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,571,735 | 531,723 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,786,751 | 189,878 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,036,000 | 191,144 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,424,179 | 191,165 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,140,676 | 142,763 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,172,725 | 134,796 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,063,899 | 99,850 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,812,055 | 78,410 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $571,668 | 71,548 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $622,467 | 71,548 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $209,569 | 71,282 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $249,487 | 71,282 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $544,382 | 68,822 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $543,195 | 69,021 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $817,561 | 67,289 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $663,481 | 54,206 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $544,684 | 52,273 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $469,934 | 52,273 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||